Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Vesilute: Evidence Summary
Evidence summary for Vesilute across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to Vesilute overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Vascular health | Tier D | 0 | No human trials exist; rodent studies report vascular function improvements but remain unverified |
| Immune modulation | Tier D | 0 | Animal data suggests immune parameter changes but no human translation has been attempted |